Single-sEV profiling identifies the TACSTD2 + sEV subpopulation as a factor of tumor susceptibility in the elderly

• Published in: Journal of nanobiotechnology Vol. 22; no. 1; p. 222
• Main Authors: Ning, Nannan, Lu, Jianying, Li, Qianpeng, Li, Mengmeng, Cai, Yanling, Wang, Hongchun, Li, Jingxin
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 03.05.2024; BMC
• Subjects: Adult; Aged; Aging; Aging - genetics; Animals; Antigens, Neoplasm - blood; Antigens, Neoplasm - genetics; Antigens, Neoplasm - metabolism; Biomarkers, Tumor - blood; Biomarkers, Tumor - genetics; Cancer; Cell Adhesion Molecules - genetics; Cell Adhesion Molecules - metabolism; Cell Line, Tumor; Cell Movement; Cell organelles; Cell Proliferation; Extracellular Vesicles - genetics; Extracellular Vesicles - metabolism; Female; Genetic aspects; Health aspects; HeLa Cells; Humans; Male; Mice; Middle Aged; Neoplasms - blood; Neoplasms - genetics; Neoplasms - metabolism; Physiological aspects; Proteomics - methods; Risk factors; sEV; TACSTD2; Tumor; Tumor markers; Up-Regulation; China; Aging; TACSTD2; Tumor; sEV
• ISSN: 1477-3155; 1477-3155
• DOI: 10.1186/s12951-024-02456-x

Aging is a very complex physiological phenomenon, and sEVs are involved in the regulation of this mechanism. Serum samples from healthy individuals under 30 and over 60 years of age were collected to analyze differences in sEVs proteomics. Based on PBA analysis, we found that sEVs from the serum of elderly individuals highly express TACSTD2 and identified a subpopulation marked by TACSTD2. Using ELISA, we verified the upregulation of TACSTD2 in serum from elderly human and aged mouse. In addition, we discovered that TACSTD2 was significantly increased in samples from tumor patients and had better diagnostic value than CEA. Specifically, 9 of the 13 tumor groups exhibited elevated TACSTD2, particularly for cervical cancer, colon cancer, esophageal carcinoma, liver cancer and thyroid carcinoma. Moreover, we found that serum sEVs from the elderly (especially those with high TACSTD2 levels) promoted tumor cell (SW480, HuCCT1 and HeLa) proliferation and migration. TACSTD2 was upregulated in the serum of elderly individuals and patients with tumors, and could serve as a dual biomarker for aging and tumors.